BaomanLi| Neuroanatomy | Best Researcher Award

Prof. BaomanLi| Neuroanatomy| Best Researcher Award

Prof . Baoman Li, China Medical University, China.

Dr. Baoman Li is a distinguished neuroscientist and forensic toxicologist whose academic and professional journey spans advanced pharmacological research and impactful discoveries in brain science. With a Ph.D. from China Medical University and postdoctoral training in the U.S., he has built a career rooted in scientific excellence and innovation. His pioneering research—ranging from CSF transport mechanisms to neuronal excitability and circadian-based psychiatric models—has been published in leading journals. As a professor and department director, he also contributes through scholarly leadership, editorial work, and mentorship, strengthening the foundation of neuroglial and toxicological research

Profile

 

Early Academic Pursuits

Dr. Baoman Li’s academic journey began with a strong foundation in medical pharmacology, culminating in a Ph.D. from China Medical University. His early academic years were marked by a keen interest in the complex interactions between drugs and neural function, particularly within the central nervous system. Motivated by a curiosity about how neurochemical pathways influence behavior and mental health, Dr. Li pursued rigorous scientific training and research, laying the groundwork for a future at the forefront of forensic toxicology and neuropharmacology.

Professional Endeavors

Following his doctoral studies, Dr. Li expanded his academic horizons as a postdoctoral researcher at the University of Rochester Medical Center in the United States from 2013 to 2014. There, he collaborated on cross-disciplinary studies, refining his expertise in neurobiology and toxicological mechanisms. Returning to China, he assumed the role of Professor and Department Director of the Forensic Analytical Toxicology Department at China Medical University. In this position, he has led numerous high-impact research initiatives, while mentoring emerging scientists and guiding departmental development.

🧠 Contributions and Research Focus

Dr. Li’s research has contributed significantly to our understanding of the brain’s physiological and pathological processes. His recent studies have been particularly groundbreaking. He identified a previously unknown ependymal cell-mediated pathway responsible for transporting cerebrospinal fluid (CSF) from the central nervous system to peripheral organs, published in PNAS in 2024. Another major discovery, published in Cell Metabolism in 2025, revealed the role of the norepinephrine–free fatty acid–Na⁺/K⁺-ATPase axis in regulating neuronal hyperexcitability and behavioral arousal. Furthermore, his 2023 work in Molecular Psychiatry introduced a novel circadian disruption-induced manic mouse model, offering new tools for bipolar disorder research.

📚 Scholarly Contributions and Thought Leadership

Beyond laboratory discoveries, Dr. Li has demonstrated scholarly leadership through his editorial work on three comprehensive books focusing on neuroglial functions and dysfunctions. These editorial endeavors reflect his deep engagement with the academic community and his commitment to synthesizing and disseminating cutting-edge knowledge. His work bridges pharmacology, neuroscience, and psychiatry, reinforcing his reputation as a thought leader in the multidisciplinary domain of brain science and mental health.

🏅 Accolades and Recognition

Dr. Li’s scientific rigor and innovative research have earned him national and international recognition. His publications in high-impact journals have attracted attention from global neuroscientific communities, affirming the relevance and importance of his findings. As a respected academic, he frequently contributes to peer-reviewed journals and serves as a reviewer and collaborator across multiple institutions, further highlighting his expertise and integrity as a scientist.

🌍 Impact and Influence

Through his research, Dr. Li has had a significant impact on the fields of forensic toxicology, neuropharmacology, and psychiatric disorder modeling. His identification of critical neural pathways and behavioral mechanisms has implications for both clinical practice and basic science. His collaborative work continues to influence ongoing studies in neuroscience and mental health treatment strategies, and his mentorship of students ensures that his influence extends to future generations of researchers.

🔬 Legacy and Future Contributions

As Dr. Baoman Li continues his work, he remains committed to pushing the boundaries of forensic neuroscience and neuropharmacology. With a legacy rooted in innovation, academic excellence, and cross-disciplinary exploration, his future contributions are expected to further transform our understanding of brain function and disease. By integrating analytical toxicology with behavioral neuroscience, Dr. Li aims to develop novel diagnostic and therapeutic approaches that could benefit public health on a global scale.

🧾 Conclusion

Through decades of dedication, Dr. Baoman Li has emerged as a transformative figure in the intersecting fields of neuropharmacology, forensic toxicology, and psychiatric neuroscience. His work not only enhances scientific understanding but also opens new avenues for diagnosis and treatment of complex neurological and psychological disorders. As he continues to lead cutting-edge research and mentor the next generation, his influence will persist—shaping the future of brain health and forensic science across global academic and clinical landscapes.

Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai, Wake Forest School of Medicine, United States.

Dr. Kiran K. Solingapuram Sai, PhD, is an Associate Professor with tenure in the Department of Radiology at Wake Forest School of Medicine. He holds a Ph.D. in Organic Chemistry from Northern Illinois University and has extensive research experience in radiopharmaceutical chemistry. His postdoctoral training at Washington University’s Mallinckrodt Institute of Radiology focused on radiotracer development.

Profile

Orcid

 

✨ Early Academic Pursuits

Dr. Kiran K. Solingapuram Sai embarked on his academic journey with a strong foundation in chemistry, earning a Bachelor of Science degree in Chemistry, Biochemistry, and Microbiology from Osmania University, Hyderabad, India, in 2001. His passion for organic chemistry led him to pursue a Master of Science in the same field at Osmania University, where he honed his expertise in chemical synthesis and molecular interactions. Determined to explore the depths of organic chemistry, he pursued his Ph.D. at Northern Illinois University, DeKalb, IL, under the mentorship of Dr. Douglas A. Klumpp. During this period, his research focused on synthetic methodologies and organic reaction mechanisms, paving the way for his future contributions to medicinal and radiopharmaceutical chemistry.

🌐 Professional Endeavors

Dr. Sai’s professional journey commenced with a prestigious postdoctoral research associate position at the Mallinckrodt Institute of Radiology at Washington University in St. Louis, MO, where he worked under the guidance of Dr. Robert H. Mach. During his tenure from 2010 to 2013, he delved into the complexities of radiochemistry, developing novel radiotracers and exploring their applications in medical imaging. This experience laid the groundwork for his career in radiopharmaceutical sciences. In 2014, he joined Wake Forest School of Medicine as a Research Instructor and Chief Radiochemist, marking the beginning of his significant contributions to translational imaging and radiopharmaceutical production.

⚛️ Contributions and Research Focus

At Wake Forest School of Medicine, Dr. Sai played a pivotal role in the Department of Radiology and the Clinical Translational Science Institute (CTSI). He specialized in managing clinical and research-based radiopharmaceutical production at the Wake Forest PET Research Center. As a cyclotron manager and coordinator, he oversaw the synthesis and quality control of radiotracers essential for PET imaging. His expertise extended to the development and implementation of cGMP-approved protocols for C-11 and F-18 radiopharmaceutical production, ensuring the highest standards of safety and efficacy. His research focuses on advancing PET imaging techniques, exploring new radiotracers for diagnostic and therapeutic applications, and improving imaging biomarker development.

🏆 Accolades and Recognition

Dr. Sai’s dedication to radiochemistry and molecular imaging has earned him recognition in the scientific community. His work has been instrumental in developing radiopharmaceuticals for neurological and oncological imaging, contributing significantly to early disease detection and targeted therapy. His contributions have been acknowledged through numerous research grants, collaborative projects, and publications in high-impact scientific journals. His commitment to excellence and innovation has positioned him as a leading figure in the field of radiopharmaceutical sciences.

🔬 Impact and Influence

Beyond his research and technical expertise, Dr. Sai has mentored budding scientists and researchers in the field of radiochemistry and imaging sciences. His guidance has helped shape the next generation of radiopharmaceutical experts, fostering a culture of innovation and scientific curiosity. His role in translational imaging programs has bridged the gap between basic research and clinical applications, directly impacting patient care by improving diagnostic imaging techniques.

💡 Legacy and Future Contributions

Dr. Sai’s work continues to inspire advancements in molecular imaging and radiopharmaceutical development. As an Associate Professor with tenure at Wake Forest School of Medicine, he remains dedicated to pushing the boundaries of radiochemistry, developing cutting-edge imaging agents, and enhancing the precision of diagnostic medicine. His legacy in the field is defined by his unwavering commitment to scientific discovery, translational research, and the continuous pursuit of excellence in radiopharmaceutical sciences.Dr. Kiran K. Solingapuram Sai’s contributions to the field of radiopharmaceutical chemistry stand as a testament to his dedication, innovation, and impact on medical imaging and healthcare. His journey from a passionate chemistry student to a distinguished professor and researcher highlights the transformative power of science in shaping the future of medicine.

 

Publication

  1. Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB

    • Authors: Naresh Damuka, George W. Schaaf, Mack Miller, Caleb Bradley, Bhuvanachandra Bhoopal, Ivan Krizan, Krishna K. Gollapelli, Christopher T. Whitlow, J. Mark Cline, Kiran K. Solingapuram Sai
    • Year: 2025

 

  1. The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

    • Authors: Hilal A. Rather, Sameh Almousa, Ashish Kumar, Mitu Sharma, Isabel Pennington, Susy Kim, Yixin Su, Yangen He, Abdollah R. Ghara, Kiran Kumar Solingapuram Sai et al.
    • Year: 2023

 

  1. Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process

    • Authors: Paul Josef Myburgh, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents

    • Authors: Avinash H. Bansode, Bhuvanachandra Bhoopal, Krishna Kumar Gollapelli, Naresh Damuka, Ivan Krizan, Mack Miller, Suzanne Craft, Akiva Mintz, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains

    • Authors: Naresh Damuka, Paul W. Czoty, Ashley T. Davis, Michael Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo Thomma, Phillip M. Epperly, Christopher T. Whitlow et al.
    • Year: 2020

 

  1. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists

    • Authors: Nagaraju Bashetti, J.V. Shanmukha Kumar, Naresh Varma Seelam, B. Prasanna, Akiva Mintz, Naresh Damuka, Sriram Devanathan, Kiran Kumar Solingapuram Sai
    • Year: 2019

 

Conclusion

Dr. Kiran K. Solingapuram Sai has established himself as a leading expert in radiopharmaceutical sciences, contributing significantly to translational imaging research. His work in PET radiopharmaceutical production and quality assurance underscores his role in advancing medical imaging techniques. His academic and research contributions make him a valuable asset in the field of radiology and molecular imaging.